Mutant P53 arrests nuclear translocation of GAPDH by activating AKT signaling and repressing AMPK signaling, which stabilizes GAPDH in the cytoplasm, and strengthens glycolysis in cancer cells while restraining nuclear GAPDH-mediated cell death mechanisms. Here, AKT1 is linked to cancer.